Prednisone and Morphea - a phase IV clinical study of FDA data

Summary:

Morphea is reported as a side effect among people who take Prednisone (prednisone), especially for people who are female, 10-19 old, also take Cellcept, and have Diffuse large b-cell lymphoma recurrent.

The phase IV clinical study analyzes which people have Morphea when taking Prednisone. It is created by eHealthMe based on reports of 628,814 people who have side effects when taking Prednisone from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Morphea?

Morphea is found to be associated with 60 drugs and 132 conditions by eHealthMe. Check the latest studies of Morphea.

On Jul, 10, 2026

628,814 people reported to have side effects when taking Prednisone.
Among them, 48 people (0.01%) have Morphea.

Among these 48 people:

What is the gender of people who have Morphea when taking Prednisone? *

female: 56.52 %
male: 43.48 %

What is the age of people who have Morphea when taking Prednisone? *

What are other drugs people take besides Prednisone? *

What are other side effects people have besides Morphea? *

Pain: 21 people, 43.75%
Rashes (redness): 17 people, 35.42%
Disease Progression: 15 people, 31.25%
Growth Retardation (delayed growth): 14 people, 29.17%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 14 people, 29.17%
Drug Ineffective: 13 people, 27.08%
Musculoskeletal Disorder (disease of the body's muscles, joints, tendons, ligaments and nerves): 13 people, 27.08%
Total Lung Capacity Decreased: 13 people, 27.08%
Malignant Neoplasm Progression (cancer tumour came back): 12 people, 25.00%
Disease Recurrence: 12 people, 25.00%

What are the existing conditions these people have? *

Testicular Neoplasm (testes tumour): 13 people, 27.08%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 13 people, 27.08%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 13 people, 27.08%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 11 people, 22.92%
Rashes (redness): 11 people, 22.92%
Nuclear Magnetic Resonance Imaging Brain: 6 people, 12.50%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.17%
Hepatitis C: 2 people, 4.17%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 2.08%
Thyroid Diseases: 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Morphea?

- Check whether Morphea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisone:

Prednisone (636,827 reports)

Morphea treatments and more:

Morphea (839 reports)

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Morphea:

Morphea (60 drugs)

Browse all the conditions that are associated with Morphea:

Morphea (132 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.